[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Human DNA Vaccines Market Report 2017

January 2018 | 103 pages | ID: UD7218C98A1EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Human DNA Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Human DNA Vaccines in these regions, from 2012 to 2022 (forecast).
United States Human DNA Vaccines market competition by top manufacturers/players, with Human DNA Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Inovio Pharmaceuticals
  • GeneOne Life Science
  • MedImmune
  • Immunomic Therapeutics
  • Astellas Pharma
  • Pharos Biologicals
  • Sanofi
  • Hoffmann-La Roche
  • CureVac
  • Boehringer Ingelheim
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Type I
  • Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Influenza
  • Human Papillomavirus
  • HIV
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human DNA Vaccines Market Report 2017

1 HUMAN DNA VACCINES OVERVIEW

1.1 Product Overview and Scope of Human DNA Vaccines
1.2 Classification of Human DNA Vaccines by Product Category
  1.2.1 United States Human DNA Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human DNA Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 United States Human DNA Vaccines Market by Application/End Users
  1.3.1 United States Human DNA Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Influenza
  1.3.3 Human Papillomavirus
  1.3.4 HIV
1.4 United States Human DNA Vaccines Market by Region
  1.4.1 United States Human DNA Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human DNA Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Human DNA Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human DNA Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Human DNA Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Human DNA Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Human DNA Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human DNA Vaccines (2012-2022)
  1.5.1 United States Human DNA Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Human DNA Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN DNA VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human DNA Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human DNA Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human DNA Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Human DNA Vaccines Market Competitive Situation and Trends
  2.4.1 United States Human DNA Vaccines Market Concentration Rate
  2.4.2 United States Human DNA Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human DNA Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN DNA VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human DNA Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Human DNA Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Human DNA Vaccines Price by Region (2012-2017)

4 UNITED STATES HUMAN DNA VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human DNA Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human DNA Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Human DNA Vaccines Price by Type (2012-2017)
4.4 United States Human DNA Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN DNA VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human DNA Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Human DNA Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN DNA VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Inovio Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human DNA Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Inovio Pharmaceuticals Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GeneOne Life Science
  6.2.2 Human DNA Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GeneOne Life Science Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 MedImmune
  6.3.2 Human DNA Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MedImmune Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Immunomic Therapeutics
  6.4.2 Human DNA Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Immunomic Therapeutics Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Astellas Pharma
  6.5.2 Human DNA Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Astellas Pharma Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pharos Biologicals
  6.6.2 Human DNA Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pharos Biologicals Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.2 Human DNA Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hoffmann-La Roche
  6.8.2 Human DNA Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hoffmann-La Roche Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 CureVac
  6.9.2 Human DNA Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CureVac Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Boehringer Ingelheim
  6.10.2 Human DNA Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Boehringer Ingelheim Human DNA Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 HUMAN DNA VACCINES MANUFACTURING COST ANALYSIS

7.1 Human DNA Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human DNA Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human DNA Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human DNA Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN DNA VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human DNA Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human DNA Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Human DNA Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Human DNA Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Human DNA Vaccines
Figure United States Human DNA Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Human DNA Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Human DNA Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Human DNA Vaccines by Application in 2016
Figure Influenza Examples
Table Key Downstream Customer in Influenza
Figure Human Papillomavirus Examples
Table Key Downstream Customer in Human Papillomavirus
Figure HIV Examples
Table Key Downstream Customer in HIV
Figure United States Human DNA Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human DNA Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Human DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human DNA Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Human DNA Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Human DNA Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human DNA Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Human DNA Vaccines Sales Share by Players/Suppliers
Figure United States Human DNA Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human DNA Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human DNA Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human DNA Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Human DNA Vaccines Revenue Share by Players/Suppliers
Table United States Market Human DNA Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Human DNA Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Human DNA Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Human DNA Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human DNA Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human DNA Vaccines Product Category
Table United States Human DNA Vaccines Sales (K Units) by Region (2012-2017)
Table United States Human DNA Vaccines Sales Share by Region (2012-2017)
Figure United States Human DNA Vaccines Sales Share by Region (2012-2017)
Figure United States Human DNA Vaccines Sales Market Share by Region in 2016
Table United States Human DNA Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human DNA Vaccines Revenue Share by Region (2012-2017)
Figure United States Human DNA Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Human DNA Vaccines Revenue Market Share by Region in 2016
Table United States Human DNA Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Human DNA Vaccines Sales (K Units) by Type (2012-2017)
Table United States Human DNA Vaccines Sales Share by Type (2012-2017)
Figure United States Human DNA Vaccines Sales Share by Type (2012-2017)
Figure United States Human DNA Vaccines Sales Market Share by Type in 2016
Table United States Human DNA Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human DNA Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human DNA Vaccines by Type (2012-2017)
Figure Revenue Market Share of Human DNA Vaccines by Type in 2016
Table United States Human DNA Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Human DNA Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Human DNA Vaccines Sales (K Units) by Application (2012-2017)
Table United States Human DNA Vaccines Sales Market Share by Application (2012-2017)
Figure United States Human DNA Vaccines Sales Market Share by Application (2012-2017)
Figure United States Human DNA Vaccines Sales Market Share by Application in 2016
Table United States Human DNA Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Human DNA Vaccines Sales Growth Rate by Application (2012-2017)
Table Inovio Pharmaceuticals Basic Information List
Table Inovio Pharmaceuticals Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Inovio Pharmaceuticals Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Inovio Pharmaceuticals Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Inovio Pharmaceuticals Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table GeneOne Life Science Basic Information List
Table GeneOne Life Science Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GeneOne Life Science Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure GeneOne Life Science Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure GeneOne Life Science Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MedImmune Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure MedImmune Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure MedImmune Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Immunomic Therapeutics Basic Information List
Table Immunomic Therapeutics Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomic Therapeutics Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Immunomic Therapeutics Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Immunomic Therapeutics Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Astellas Pharma Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Pharos Biologicals Basic Information List
Table Pharos Biologicals Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pharos Biologicals Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Pharos Biologicals Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Pharos Biologicals Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Hoffmann-La Roche Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Hoffmann-La Roche Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table CureVac Basic Information List
Table CureVac Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CureVac Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure CureVac Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure CureVac Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Human DNA Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Human DNA Vaccines Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Human DNA Vaccines Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Human DNA Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human DNA Vaccines
Figure Manufacturing Process Analysis of Human DNA Vaccines
Figure Human DNA Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Human DNA Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Human DNA Vaccines
Table Distributors/Traders List
Figure United States Human DNA Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Human DNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human DNA Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Human DNA Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human DNA Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human DNA Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Human DNA Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human DNA Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human DNA Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Human DNA Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Human DNA Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human DNA Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human DNA Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories